Pacific Point Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Sell
872
-32
-4% -$15.4K 0.2% 92
2026
Q1
$444K Buy
904
+7
+0.8% +$3.8K 0.23% 93
2025
Q4
$520K Hold
897
0.28% 94
2025
Q3
$435K Buy
897
+22
+3% +$10.2K 0.25% 90
2025
Q2
$355K Hold
875
0.19% 91
2025
Q1
$435K Hold
875
0.24% 84
2024
Q4
$508K Buy
+875
New +$481K 0.31% 77

Other funds holding TMO

Pacific Point Advisors's TMO Position: Q2 2026 in Review

Pacific Point Advisors reduced its Thermo Fisher Scientific (TMO) stake by 3.5% in Q2 2026, selling an estimated $15.4K and leaving 872 shares worth $437K. The position accounts for 0.2% of the portfolio, ranked #92.

Pacific Point Advisors first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $520K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Pacific Point Advisors held 872 shares of Thermo Fisher Scientific worth $437K as of Q2 2026.
  • Pacific Point Advisors sold 32 Thermo Fisher Scientific shares in Q2 2026, an estimated $15.4K.
  • Thermo Fisher Scientific made up 0.2% of Pacific Point Advisors's portfolio in Q2 2026, its #92 holding.
  • Pacific Point Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Pacific Point Advisors's Thermo Fisher Scientific position peaked at $520K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Pacific Point Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.